Investing in MegaTrends

Bitcoin mania and bullishness in the artificial intelligence sector saw UK traders increase their positions in some popular stocks.

Nvidia disappointed investors with its presentation in Las Vegas this month, but there are positive implications for other sectors here.

Association of Investment Companies' members tip healthcare, technology and North America as the best-performing sectors for 2025

Seven & i holdings in Japan considers IPO of US assets, biotech companies could be coming back to the market, and a Chicago casino.

We take a closer look at Spectrum X, a UK biotech company which could list next year, and is currently taking on pre-IPO investment.

Benchmark has had a challenging year, but the disposal of its Genetics division sparks a new direction and return of capital to shareholders

Pila Pharma's stock has been bid up over 140% since the start of the year as it pushes ahead with research into Type 2 diabetes treatment.

Saxo Bank has published its annual list of outrageous predictions for 2025 to illustrate some of the uncertainties that could affect markets

Monzo CFO appointment sparks IPO expectations, CoreWeave aims for $35bn valuation in 2025 IPO, Odyssey Therapeutics meets investors pre-IPO.

This AIM-listed software and computer services stock specialising in data and AI has published its interim results

China tech champion sees its stock rally again following substantial first half loss - will we see more in 2025?

This week we are tipping a China-based pioneer in healthcare devices which you can wear to keep track of essential readings.

One Health Group improves earnings and expects to exceed its previous year-end forecast following resolution of the NHS junior doctors' strike

Canadian miner Brazil Potash aims to get an IPO away in New York, while drug maker Apotex may test market next year.

Fresh from our tour of Japan, we look at five of the top large cap stocks currently trading on the Tokyo Stock Exchange.

The integration of AI into drug discovery is reshaping the biotech and healthcare landscape. Here's how you can invest in these advancements

Biotech company Septerna is coming to NASDAQ, Swiggy cuts its IPO valuation and Hong Kong is back in business with Horizon Robotics IPO

Tecan Group's share price continues to fall, but is this true of the rest of the healthcare sector in Switzerland?

This guide is designed to help investors evaluate their exposure to the dynamic and rapidly evolving fields of Artificial Intelligence and robotics

Snowflake has taken a beating over the summer. Can this tech stock rally, or are there better options for investors?

Concerns still swirl around the Cerebras IPO due to the absence of the big tech banks, while London gets ready for Applied Nutrition.

Oxford Biodynamics reports increased orders for prostrate cancer test, but high cash-burn leads to strategic review and cost cutting measures

On the podcast this week we speak with legendary US money manager Cathie Wood, CEO of ARK Invest, about US equity markets.

A tech start up from Lithuania is pioneering a new AI-driven service to help with sorting and reusing unwanted LEGO bricks.

Perimeter Medical Imaging has a major sugar daddy but investors have been worried about his commitment to the stock: is he still on board?

Ryan Reynolds' ad company sits down with Morgan Stanley to talk IPO plans, while a $200m healthcare SPAC hits the market.

Ocean Harvest sees a disappointing first half but successful trials and new finance point to a brighter second half

Animalcare has a transformational year as disposal of Identicare and STEM sees cash position swell to GBP32.9m

We take a look at technological revolutions of the past and how investors can position themselves for the Artificial Intelligence revolution

Applied Nutrition said it would be seeking to float on the LSE main board at some time in the course of Q4.

Japanese SSD maker Kioxia is relaunching its IPO bid in Tokyo after a four year hiatus, while MBX Biosciences files in the US.

The spread of mpox in Africa is shifting billions into the healthcare sector: here we look at five of the best stocks in healthcare.

Stocks of vaccine makers and manufacturers of testing equipment surge as mpox virus spreads in central Africa.

AQSE-listed cosmetics group Incanthera said it has radically expanded the size of its initial skincare launch in Europe.

IntelliAM doesn't let moss grow under its feet as rolls forward from IPO earlier this month with research grant from Digital Innovation Fund

ECO Animal Healthcare moves the needle in the right direction as it delivers a positive set of final results

A new fund analysis solution will provide high levels of detail into funds including ETFs and their underlying assets.

Latest intel from AML Group shows that UK investor confidence has returned to pre-pandemic levels for the first time.

Mobeen Tahir of WisdomTree joins us again to talk Cloud Computing, AI, Cybersecurity and the Internet of Things

EDX Medical rapidly grows through new capital investment and acquisition. EDX shares offer +100% return over one-year

Brightwave has already been making waves in the hedge fund space, where managers are leveraging its unique perspectives.

AIPI is designed to provide investors with exposure to leading AI companies while aiming for an enhanced monthly income.

Massive interest in anti-obesity drugs has driven the share price of Novo Nordisk and Eli Lilly to dizzying heights.

Theracryf poised for growth despite weak share price. Acquisition boosts pipeline expanding into behavioural brain disorders

FD Technologies share price is down 30% in a year but its restructuring process could unlock value for patient investors

On this podcast, Paul Major, Investment Manager of Bellevue Healthcare Trust talks to Stuart Fieldhouse about the Healthcare sector

This week we are buying a US large cap health insurance specialist which is using technology to deliver a better experience for customers.

Voyager Life continues a year of progress seeking to diversify its production chain vertically despite two failed acquisitions

Headlines are being dominated by Artificial Intelligence stocks and whether they are overbought but earnings season has given us evidence

ECO Animal Health has published a positive trading update to emerge from the sector's dark cloud with analysts seeing a buying opportunity